header

TET2 mutation in myeloid neoplasms /

Lucie Gamal Fawzi

TET2 mutation in myeloid neoplasms / الطفرة الكروموزمية فى الورم الميلودى:TET2 Lucie Gamal Fawzi ; Supervised Aisha Mostafa Abdelraman , Hoda Mohamed Abdelghany , Reham Ahmed Rashed - Cairo : Lucie Gamal Fawzi , 2013 - 127 P. : facsimiles ; 25cm

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

In acute myloid leukemia (AML), both cytogenetic and molecular abnrmalities are strongly assosiated with prognosis. In particular, in cytogenetically normal AML. Families of myeloproliferaive neoplasms (MPNs) are characterized by a clinical and genetic heterogenceity. First, within MPN families, distinct clinical entities are observed, the 3 main ones being polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PME)



Acute lymphoblastic leukemia Alpha naphthly acetate Primary myelofibrosis (PME)